Singapore: Lignol Energy (LEC) has applied for and has been granted approval by the Australian Foreign Investment Review...
Singapore: The national health report released by the Federal Government's Australian Institute of Health and Welfare ha...
Singapore: CSL announced that it had successfully completed the four year investigation, probing into the side effects c...
Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials ...
Singapore: 20th International AIDS Conference (AIDS 2014), kicked off in Melbourne on July 20th, with a gathering of ove...
Singapore: Australia-based Allied Healthcare has marked a stronger sales with revenues up at 13 percent to $3.7 million ...
Singapore: Senator Kate Lundy, the Australian minister assisting for industry and innovation, has launched Australian ...
Singapore: Australian firm AtCor Medical, a developer and marketer of the SphygmoCor system that measures central aorti...
Singapore: ResMed, Australian developer, manufacturer and distributor of sleep and respiratory medical equipment, has l...
Singapore: Almirall granted commercial rights for Aclidinium in Australia and New Zealand for the treatment of chronic ...
Singapore: Viralytics' American Depository Receipts (ADRs) have commenced trading on OTCQX International. ADRs trade und...
Singapore: Allied Healthcare has lodged its Premarket Notification 510(k) Submission for CardioCel in the US. The FDA 51...
Singapore: Eminent AIDS researcher, Prof Joep Lange, died in the Malaysian Airlines flight MH17 crash on July 17 while h...
Australian drug delivery technology company Imugene has developed Linguet, a drug delivery technology platform, to impro...
I think there will be continuing of existing trends in 2013 as well. We expect to see ongoing growth in the point-of-car...
Singapore: World leaders and policy makers have gathered in Doha, Qatar, to discuss innovative solutions to the most pre...
Singapore: Australia's Mayne Pharma plans to acquire Kapanol and related assets in Australia from GlaxoSmithKline (GSK)....
Singapore: Patrys, a clinical stage biopharmaceutical company, received approval to progress its phase I/IIa PAT-SM6 mu...
